Cargando…
Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD)
End-stage renal disease (ESRD) is the final stage of chronic kidney disease, which is increasingly prevalent worldwide and is associated with the progression of cardiovascular disease (CVD). Indoxyl sulfate (IS), a major uremic toxin, plays a key role in the pathology of CVD via adverse effects in e...
Autores principales: | Kim, Hee Young, Lee, Su Jeong, Hwang, Yuri, Lee, Ga Hye, Yoon, Chae Eun, Kim, Hyeon Chang, Yoo, Tae-Hyun, Lee, Won-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601745/ https://www.ncbi.nlm.nih.gov/pubmed/32998431 http://dx.doi.org/10.3390/toxins12100621 |
Ejemplares similares
-
Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)
por: Kim, Hee Young, et al.
Publicado: (2017) -
Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages
por: Barisione, Chiara, et al.
Publicado: (2016) -
Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020) -
p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
por: Hyun, Hye Sun, et al.
Publicado: (2013) -
Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020)